Cargando…

Endogenous versus exogenous cell replacement for Parkinson’s disease: where are we at and where are we going?

Parkinson’s disease is the second most common neurodegenerative disease and has currently no effective treatment, one that would be able to stop or reverse the loss of dopaminergic neurons in the substantia nigra pars compacta. In addition, Parkinson’s disease diagnosis is typically done when a sign...

Descripción completa

Detalles Bibliográficos
Autores principales: Mourtzi, Theodora, Kazanis, Ilias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165379/
https://www.ncbi.nlm.nih.gov/pubmed/35662194
http://dx.doi.org/10.4103/1673-5374.336137

Ejemplares similares